Report
Joel Litman ...
  • Rob Spivey

Valens Market Phase Cycle Monitor & Corporate Credit Macro View - October 2018

Any time the market falls 6%+ in 2 days, investors justifiably ask whether something has changed that should impact their investment thesis. This is when a consistent framework like the Market Phase Cycle is most valuable.

That framework says that nothing has changed about the fundamental backdrop that has given us reason to consistently tell investors to “buy the dip” the last several years.

None of the key indicators we monitor have turned more negative. The only factor that has changed significantly in the last month is investor sentiment has gone from being bullish to extremely bearish, a classic sign of capitulation. All of the fundamental indicators that we monitor are giving positive signals.

We are in an environment with strong EPS' growth, forecast to be 14% a year in 2018 and 2019, and we are seeing ROA' improving to historically high levels, on a sustainable trend. At the same time, valuations remain low, with the market pricing in ROA' to remain at 2014-2015 trough levels.

Management teams continue to get more confident about investing in growth, which is likely to continue to fuel a virtuous circle of increasing capex and therefore increasing demand, sustaining expectations for earnings growth.

Lastly, credit fundamentals remain healthy, and cost to borrow remains reasonable, limiting the risk of growth being stifled by credit markets.

Considering all the positive signals we are seeing for US corporations right now, this sell-off doesn't appear to be a reason to worry about having been tricked by the market. It appears to be a treat for investors who are open to buying the dip yet again.
Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Joel Litman

Rob Spivey

Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch